STOCK TITAN

Morgan Stanley (NYSE: MS) shares Q4 and full-year 2025 results details

Filing Impact
(Moderate)
Filing Sentiment
(Neutral)
Form Type
8-K

Rhea-AI Filing Summary

Morgan Stanley filed a current report to note that it has released financial information for its quarter and year ended December 31, 2025. The company issued a press release and a detailed Financial Data Supplement, which are attached as Exhibits 99.1 and 99.2, and form part of this report.

The bank also prepared an investor presentation, filed as Exhibit 99.3, to accompany an investor conference call discussing these results. The materials include forward-looking statements, and the company highlights that actual outcomes may differ due to various risks and uncertainties described in its prior annual and quarterly reports.

Positive

  • None.

Negative

  • None.
false000089542100008954212026-01-152026-01-150000895421us-gaap:CommonClassAMember2026-01-152026-01-150000895421us-gaap:SeriesAPreferredStockMember2026-01-152026-01-150000895421us-gaap:SeriesEPreferredStockMember2026-01-152026-01-150000895421us-gaap:SeriesFPreferredStockMember2026-01-152026-01-150000895421ms:SeriesIPreferredStockMember2026-01-152026-01-150000895421ms:SeriesKPreferredStockMember2026-01-152026-01-150000895421ms:SeriesLPreferredStockMember2026-01-152026-01-150000895421ms:SeriesOPreferredStockMember2026-01-152026-01-150000895421ms:SeriesPPreferredStockMember2026-01-152026-01-150000895421ms:SeriesQPreferredStockMember2026-01-152026-01-150000895421ms:GlobalMediumTermNotesSeriesAFixedRateStepUpSeniorNotesDue2026OfMorganStanleyFinanceLLCMember2026-01-152026-01-150000895421ms:GlobalMediumTermNotesSeriesAFloatingRateNotesDue2029OfMorganStanleyFinanceLLCMember2026-01-152026-01-15

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
 
FORM 8-K
CURRENT REPORT
Pursuant To Section 13 or 15(d) of
the Securities Exchange Act of 1934
Date of report (Date of earliest event reported): January 15, 2026
 
Morgan Stanley
(Exact Name of Registrant
as Specified in Charter)
 
   
 
Delaware1-1175836-3145972
(State or Other Jurisdiction of Incorporation)(Commission File Number)(IRS Employer Identification No.)
 
1585 Broadway, New York, New York
 
10036
(Address of Principal Executive Offices) (Zip Code)
 
   
Registrant’s telephone number, including area code: (212) 761-4000
 
Not Applicable
(Former Name or Former Address, if Changed Since Last Report)

 
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act:
Title of each classTrading Symbol(s)Name of each exchange on which registered
Common Stock, $0.01 par valueMSNew York Stock Exchange

    


Title of each classTrading Symbol(s)Name of each exchange on which registered
Depositary Shares, each representing 1/1,000th interest in a share of Floating Rate Non-Cumulative Preferred Stock, Series A, $0.01 par value
MS/PANew York Stock Exchange
Depositary Shares, each representing 1/1,000th interest in a share of Fixed-to-Floating Rate Non-Cumulative Preferred Stock, Series E, $0.01 par value
MS/PENew York Stock Exchange
Depositary Shares, each representing 1/1,000th interest in a share of Fixed-to-Floating Rate Non-Cumulative Preferred Stock, Series F, $0.01 par value
MS/PFNew York Stock Exchange
Depositary Shares, each representing 1/1,000th interest in a share of Fixed-to-Floating Rate Non-Cumulative Preferred Stock, Series I, $0.01 par value
MS/PINew York Stock Exchange
Depositary Shares, each representing 1/1,000th interest in a share of Fixed-to-Floating Rate Non-Cumulative Preferred Stock, Series K, $0.01 par value
MS/PKNew York Stock Exchange
Depositary Shares, each representing 1/1,000th interest in a share of 4.875% Non-Cumulative Preferred Stock, Series L, $0.01 par value
MS/PLNew York Stock Exchange
Depositary Shares, each representing 1/1,000th interest in a share of 4.250% Non-Cumulative Preferred Stock, Series O, $0.01 par value
MS/PONew York Stock Exchange
Depositary Shares, each representing 1/1,000th interest in a share of 6.500% Non-Cumulative Preferred Stock, Series P, $0.01 par value
MS/PPNew York Stock Exchange
Depositary Shares, each representing 1/1,000th interest in a share of 6.625% Non-Cumulative Preferred Stock, Series Q, $0.01 par value
MS/PQNew York Stock Exchange
Global Medium-Term Notes, Series A, Fixed Rate Step-Up Senior Notes Due 2026 of Morgan Stanley Finance LLC (and Registrant’s guarantee with respect thereto)
MS/26CNew York Stock Exchange
Global Medium-Term Notes, Series A, Floating Rate Notes Due 2029 of Morgan Stanley Finance LLC (and Registrant’s guarantee with respect thereto)
MS/29New York Stock Exchange

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  
 
 


    


 
Item 2.02 Results of Operations and Financial Condition.

On January 15, 2026, Morgan Stanley (the "Company") released financial information with respect to its quarter and year ended December 31, 2025. A copy of the press release containing this information is annexed as Exhibit 99.1 to this Report and by this reference incorporated herein and made a part hereof. In addition, a copy of the Company's Financial Data Supplement for its quarter and year ended December 31, 2025 is annexed as Exhibit 99.2 to this Report and by this reference incorporated herein and made a part hereof.

The information furnished under Item 2.02 of this Report, including Exhibit 99.1 and Exhibit 99.2, shall be deemed to be "filed" for purposes of the Securities Exchange Act of 1934, as amended.

Item 7.01 Regulation FD Disclosure.

On January 15, 2026, Morgan Stanley (the “Company”) released financial information with respect to its quarter and year ended December 31, 2025 and will hold an investor conference call. Exhibit 99.3 is a copy of a presentation (the “Presentation”) to be presented on the conference call, furnished for, and posted on the Company’s website.

The Presentation is being furnished pursuant to Item 7.01, and the information contained therein shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities under that Section. Furthermore, the information contained in Exhibit 99.3 shall not be deemed to be incorporated by reference into the filings of the Registrant under the Securities Act of 1933, as amended.

Item 7.01 of this Current Report on Form 8-K (including Exhibit 99.3 hereto) contains forward-looking statements, including the attainment of certain financial and other targets, objectives and goals. Readers are cautioned not to place undue reliance on forward-looking statements, which speak only as of the date on which they are made, which reflect management's current estimates, projections, expectations, assumptions, interpretations or beliefs and which are subject to risks and uncertainties that may cause actual results to differ materially. Morgan Stanley does not undertake to update the forward-looking statements to reflect the impact of circumstances or events that may arise after the date of the forward-looking statements. For a discussion of risks and uncertainties that may affect the future results of Morgan Stanley, please see “Forward-Looking Statements” preceding Part I, Item 1, “Competition” and “Supervision and Regulation” in Part I, Item 1, “Risk Factors” in Part I, Item 1A, “Legal Proceedings” in Part I, Item 3, “Management’s Discussion and Analysis of Financial Condition and Results of Operations” in Part II, Item 7 and “Quantitative and Qualitative Disclosures about Risk” in Part II, Item 7A in Morgan Stanley’s Annual Report on Form 10-K for the year ended December 31, 2024 and other items throughout the Form 10-K, Morgan Stanley’s Quarterly Reports on Form 10-Q, Morgan Stanley’s Current Reports on Form 8-K, including any amendments thereto, which have been filed with the Securities and Exchange Commission and are available on Morgan Stanley’s website at www.morganstanley.com and on the Securities and Exchange Commission’s website at www.sec.gov.

Item 9.01  
Financial Statements and Exhibits. 
 
(d)       Exhibits 
 
Exhibit  
Number
Description  
99.1
Press release of the Company, dated January 15, 2026, containing financial information for the quarter and year ended December 31, 2025.
99.2
Financial Data Supplement of the Company for the quarter and year ended December 31, 2025.
99.3
Morgan Stanley Presentation, dated on January 15, 2026.
101Interactive Data Files pursuant to Rule 406 of Regulation S-T formatted in Inline eXtensible Business Reporting Language (“Inline XBRL”).
104Cover Page Interactive Data File (formatted in Inline XBRL and contained in Exhibit 101).



    


SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, hereunto duly authorized.
  MORGAN STANLEY
(Registrant)
Date:
January 15, 2026
 By:/s/ Victoria Worster
    Name:Victoria Worster
    Title:Chief Accounting Officer and Controller


    

FAQ

What did Morgan Stanley (MS) report in this 8-K filing?

Morgan Stanley reported that it released financial information for its quarter and year ended December 31, 2025, including a press release, Financial Data Supplement, and an investor presentation.

Which period do the new Morgan Stanley (MS) financial disclosures cover?

The disclosures cover Morgan Stanley’s quarter and full year ended December 31, 2025.

What is contained in Exhibits 99.1 and 99.2 for Morgan Stanley (MS)?

Exhibit 99.1 is a press release with financial information for the quarter and year ended December 31, 2025, and Exhibit 99.2 is a Financial Data Supplement for the same period.

What is Exhibit 99.3 in Morgan Stanley’s (MS) 8-K?

Exhibit 99.3 is a presentation used for an investor conference call, dated January 15, 2026, and posted on Morgan Stanley’s website.

Are the Morgan Stanley (MS) presentation materials considered filed with the SEC?

The presentation in Exhibit 99.3 is furnished under Regulation FD and is not deemed filed for purposes of Section 18 of the Exchange Act or incorporated by reference into Securities Act filings.

What forward-looking statement cautions does Morgan Stanley (MS) provide?

Morgan Stanley states that forward-looking statements reflect management’s current expectations and are subject to risks and uncertainties, directing readers to risk discussions in its Form 10-K for the year ended December 31, 2024 and subsequent Form 10-Qs.
Morgan Stanley

NYSE:MS

MS Rankings

MS Latest News

MS Latest SEC Filings

MS Stock Data

290.46B
1.21B
23.85%
62.61%
0.92%
Capital Markets
Security Brokers, Dealers & Flotation Companies
Link
United States
NEW YORK